Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive <sup>99 m</sup>Tc-Labeled Pyrophosphate Scintigraphy Findings-Reference-Cited by-同舟云学术

Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive <sup>99 m</sup>Tc-Labeled Pyrophosphate Scintigraphy Findings

Published:2022-06-24 Issue:7 Volume:86 Page:1113-1120
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nishi Masato¹,Takashio Seiji¹,Morioka Mami¹,Fujiyama Akira¹,Nakashima Naoya¹,Hirakawa Kyoko¹,Hanatani Shinsuke¹,Usuku Hiroki¹,Yamamoto Eiichiro¹,Kidoh Masafumi²,Oda Seitaro²,Gushima Ryosuke³,Matsushita Kenichi¹,Fukushima Satoshi⁴,Ueda Mitsuharu⁵,Tsujita Kenichi¹

Affiliation:

1. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

2. Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University

3. Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University

4. Department of Dermatology and Plastic Surgery, Graduate School of Medical Sciences, Kumamoto University

5. Department of Neurology, Graduate School of Medical Sciences, Kumamoto University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/86/7/86_CJ-22-0118/_pdf

Reference26 articles.

1. 1. Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. J Cardiol 2018; 71: 135–143.

2. 2. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 2017; 135: 1357–1377.

3. 3. González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585–2594.

4. 4. Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 2021; 77: 128–139.

5. 5. Benson MD, Dasgupta NR, Rissing SM, Smith J, Feigenbaum H. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. Amyloid 2017; 24: 217–223.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases;Internal Medicine;2024

2. Case Report: Transthyretin Glu54Leu—a rare mutation with predominant cardiac phenotype;Frontiers in Cardiovascular Medicine;2023-10-31

3. Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal;Orphanet Journal of Rare Diseases;2023-10-12

4. Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis;Circulation Reports;2023-07-10